Harnessing Real-World Evidence: Best Practices for Medical Affairs Teams

Real-world evidence (RWE) is transforming medical affairs by providing insights from everyday medical practice, unlike traditional clinical trials. Including data from electronic health records, insurance claims, patient registries and wearable devices, RWE offers a broader understanding of treatment outcomes.

For medical affairs teams, RWE is essential for driving better patient outcomes, informing clinical decisions and supporting regulatory submissions. Challenges arising around data quality, integration and compliance, however, must be addressed.

FirstWord spoke to Stephen Camper, a medical affairs consultant to the pharma industry, about the strategies and best practices medical affairs teams can use to overcome obstacles, ensure data integrity and maximise RWE's impact on healthcare.

Key Questions Answered:

• 1. Can you share a bit about your background and experience with RWE in medical affairs?
• 2. How has your role evolved with the increasing importance of RWE?
• 3. What are the key steps to start successfully integrating RWE into medical affairs strategies?
• 4. Can you provide examples of successful RWE implementation in your organisation or industry?
• 5. What are the common challenges medical affairs teams face when using RWE?
• 6. What best practices would you recommend for medical affairs teams to maximise the value of RWE?
• 7. How can teams ensure the quality and reliability of the RWE they use?
• 8. What regulatory and ethical considerations should medical affairs teams keep in mind when using RWE?
• 9. How do you ensure compliance with these regulations?
• 10. What future trends do you foresee in the use of RWE in medical affairs?
• 11. How can medical affairs teams prepare for these trends?

Methodology

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.